Multidrug resistant tuberculosis

Millard, James; Ugarte Gil, Cesar Augusto; Moore, David Alexander James

dc.contributor.author	Millard, James
dc.contributor.author	Ugarte Gil, Cesar Augusto
dc.contributor.author	Moore, David Alexander James
dc.date.accessioned	2019-02-06T14:59:05Z
dc.date.available	2019-02-06T14:59:05Z
dc.date.issued	2015
dc.identifier.uri	https://hdl.handle.net/20.500.12866/5517
dc.description.abstract	Tuberculosis remains a major cause of morbidity and mortality globally, with an estimated nine million people developing the disease and 1.5 million deaths in 2013; equating to 4100 deaths a day.1 Nevertheless, considerable gains have been made in international tuberculosis control; incidence rates are decreasing (albeit slowly) and mortality has been reduced by 45% worldwide. The advent of multidrug resistant tuberculosis threatens this progress. In this review we detail the challenges faced globally in the diagnosis, treatment, and control of multidrug resistant tuberculosis and why this matters to high and low burden multidrug resistant tuberculosis settings alike...	en_US
dc.language.iso	eng
dc.publisher	BMJ Publishing Group
dc.relation.ispartofseries	BMJ
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	Humans	en_US
dc.subject	Global Health	en_US
dc.subject	Risk Factors	en_US
dc.subject	Drug Therapy, Combination	en_US
dc.subject	Phenotype	en_US
dc.subject	Genotype	en_US
dc.subject	Public Health	en_US
dc.subject	Microbial Sensitivity Tests	en_US
dc.subject	Prognosis	en_US
dc.subject	Antitubercular Agents/therapeutic use	en_US
dc.subject	Forecasting	en_US
dc.subject	Drug Administration Schedule	en_US
dc.subject	Isoniazid/therapeutic use	en_US
dc.subject	Palliative Care	en_US
dc.subject	Rifampin/therapeutic use	en_US
dc.subject	Tuberculosis, Multidrug-Resistant/diagnosis/drug therapy/mortality	en_US
dc.title	Multidrug resistant tuberculosis	en_US
dc.type	info:eu-repo/semantics/review
dc.identifier.doi	https://doi.org/10.1136/bmj.h882
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.00
dc.relation.issn	1756-1833